20xx年醫(yī)學(xué)專題—潘長玉2型糖尿病血糖控制的意義及實(shí)踐(文件)
【正文】 四頁。,血糖(xu232。ng)控制的亞洲標(biāo)準(zhǔn),6.5%, 6.5 25.9%,第二十三頁，共三十四頁。 NEJM。,血糖監(jiān)測與血糖控制(k242。t225。ng)監(jiān)測與HbA1c的關(guān)系,Karter AJ et al. Am J Med 111:19, 2001,第二十九頁，共三十四頁。)的要求,Regular monitoring depending on treatment regimen, changes occurring, and history of hypoglycemic recognition Varies from 7 times daily Increase when medications are changed, other medical illnesses occur, or lifestyle changes (e.g. exercise patterns) Monitor responses to exercise Monitor responses to specific foods,第三十一頁，共三十四頁。,第三十二頁，共三十四頁。ng)總結(jié),2型糖尿病血糖控制的意義及實(shí)踐(sh237。1027例NIDDM隨機(jī)分為5組，每組約200例。Thanks,第三十四頁，共三十四頁。血清肌酐≥1.5 mg/dl 11.6 14.0 14.4。n) 解放軍總醫(yī)院 潘長玉 2003年03月15日。,內(nèi)容(n232。li225。)頻率與HbA1c的關(guān)系 F ( 2型糖尿病患者),Blonde et al. Diabetes Care 25:245, 2002.,228 patients and 3000 clinic visits,第三十頁，共三十四頁。,血糖(xu232。)的關(guān)系,Kaiser Permanente of Northern California 24312 adult patients with diabetes Found a direct relationship between frequency of testing and glucose control Even those without pharmacologic treatment had better glucose control with more monitoring. Monitoring 3 times daily or more was associated with 1% lower HbA1c in insulin treated patients and 0.6% in those on oral agents,第二十七頁，共三十四頁。 t243。,第二十五頁，共三十四頁。ng)控制,0,5,10,15,8.7,FBG (mmol/l),0,5,10,7.7,HbA1C (%),? 6.1 18.4%,最佳血糖(xu232。t225。,血 糖 控 制 的 要 求,①符合生理需要（空腹(kōngf249。,中成藥 (12%),未用口服(kǒuf jiān)胰島素的作用,Reduce nocturnal hepatic glucose production (fights “dawn phenomenon”) Requires lower insulin levels than those required for stimulating intramuscular glucose uptake Reduces glucotoxicity elevated glucose levels create insulin resistance elevated glucose levels reduce beta cell response,第十八頁，共三十四頁
化學(xué)相關(guān)推薦
鄂ICP備17016276號-1